SHetA2 reduced the metabolites in glycolysis downstream of TPI1, the tricarboxylic acid cycle and oxidative pentose phosphate pathway.<h4>Conclusions</h4>TPI1 is a candidate functional biomarker of SHetA2 sensitivity in ovarian cancer. This evidence concerns the gene TPI1 and ovarian cancer.